Related Experiment Videos
Economic issues in lung cancer
1Department of Medicine, Toronto-Sunnybrook Regional Cancer Centre, Ontario, Canada.
Seminars in Respiratory and Critical Care Medicine
|August 10, 2005
Summary
Lung cancer management is moderately expensive, but current diagnostic and treatment approaches are largely cost-effective. Further exploration is needed into inconsistent medical practices for lung cancer care.
Area of Science:
- Health Economics
- Oncology
- Public Health
Background:
- Lung cancer presents a significant societal cost due to its high incidence.
- Effective management strategies are crucial to mitigate economic burdens.
- Variations in clinical practice necessitate an economic evaluation.
Purpose of the Study:
- To review the economics of lung cancer management.
- To analyze the costs associated with diagnosis, treatment, and palliation.
- To assess the cost-effectiveness of current lung cancer interventions.
Main Methods:
- A comprehensive review of economic and methodological literature.
- Analysis of costs related to lung cancer diagnosis, staging, and treatment.
- Evaluation of cost-effectiveness of combined modality therapy and palliative chemotherapy.
Main Results:
- Lung cancer treatment is moderately expensive, contributing to significant overall societal costs.
- Judicious use of diagnostic and staging procedures can minimize costs.
- Combined modality therapy and palliative chemotherapy demonstrate reasonable cost-effectiveness.
Conclusions:
- Current lung cancer diagnosis and treatment strategies are generally cost-effective.
- Optimizing diagnostic procedures can reduce staging costs.
- Investigating the reasons behind inconsistent clinical practice patterns in lung cancer management is recommended.